CDSCO

Lupin Digital Health’s Lyfe Platform gets Class C Medical Device License from CDSCO

Read more

ENTOD Pharma gets CDSCO approval for eye drops to treat presbyopia

Read more

The emergence of india’s life science powerhouses: A deep dive

Read more

AstraZeneca India gets dual CDSCO approval for Trastuzumab deruxtecan

Read more

Cipla receives USFDA approval for plazomicin injection in India

Read more

Glenmark partners with Pfizer to launch Abrocitinib in India

Read more

AstraZeneca receives CDSCO approval to import and market Andexanet Alfa in India

Read more

Will 2024 be a year of regulatory renaissance?

Read more

AstraZeneca receives CDSCO approval to market its inhalation aerosol

Read more

Zydus begins Phase II trial of ZYIL1, NLRP3 inhibitor in patients with ALS

Read more